| 33.13 Real-Time Quote |  +0.29 / +0.88%Today’s Change | 30.42 Today|||52-Week Range 35.42 | -- Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Generic | MARKET CAP $16.4B |
Zoetis, Inc. 235 East 42nd Street New York New York 10017-5703 |
| Individual stakeholders | 87.00% |
| Other institutional | 77.62% |
| Mutual fund holders | 17.39% |
| Juan Ramón Alaix | President, Chief Executive Officer & Director |
| Richard A. Passov, MBA | Chief Financial Officer & Executive Vice President |
| Catherine Ann Knupp, DVM | Executive VP, President-Research & Development |
| Alejandro Bernal, DVM, MBA | Executive Vice President & President-EMEA Region |
| Heidi C. Chen | Secretary, Executive VP & General Counsel |
.
